Association of visceral fat area with early-stage locomotive syndrome across various age groups: a cross-sectional study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 08 04 2024
accepted: 14 10 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 27 10 2024
Statut: epublish

Résumé

The association between visceral fat area (VFA) and locomotive syndrome (LS) has been extensively studied in the older population; however, the association between VFA and early-stage LS (stage 1 [LS1]) remains unclear. In this cross-sectional study, we investigated this association across different age groups. The study involved 1,236 (524 male and 712 female) participants (aged 20-85 years). Multiple regression analysis adjusted for sex, body mass index, skeletal muscle mass index, T-score, exercise habits, smoking status, and alcohol consumption revealed a significant association between LS1 and VFA across all VFA quartiles. The adjusted odds ratio OR for quartiles 2, 3, and 4 was 1.84, 2.68, and 4.12, respectively. The association between LS1 and VFA across the age groups-high VFA (> 73 cm

Identifiants

pubmed: 39462134
doi: 10.1038/s41598-024-76478-8
pii: 10.1038/s41598-024-76478-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25498

Subventions

Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210
Organisme : Japan Science and Technology Corporation
ID : JPMJCE1302, JPMJCA2201, JPMJPF2210

Informations de copyright

© 2024. The Author(s).

Références

Cabinet Office Japan. Annual Report on the Aging Society. https://www8.cao.go.jp/kourei/whitepaper/w-2023/zenbun/pdf/1s1s_01.pdf (2023). Accessed 27 Oct 2023.
Ministry of Health, Labour and Welfare, Japan. Long-Term Care Insurance Business Status Report. https://www.mhlw.go.jp/topics/kaigo/osirase/jigyo/m23/dl/2304a.pdf (2023). Accessed 27 Oct 2023.
Ministry of Health, Labour and Welfare, Japan. Overview of the 2022 National Survey on the Basic Livelihood of the People. https://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa22/dl/14.pdf (2023). Accessed 27 Oct 2023.
Nakamura, K. A “super-aged” society and the “locomotive syndrome”. J. Orthop. Sci. 13, 1–2 (2008).
doi: 10.1007/s00776-007-1202-6 pubmed: 18274847 pmcid: 2779431
Imagama, S. et al. Staged decrease of physical ability on the locomotive syndrome risk test is related to neuropathic pain, nociceptive pain, shoulder complaints, and quality of life in middle-aged and elderly people—The utility of the locomotive syndrome risk test. Mod. Rheumatol. 27, 1051–1056 (2017).
doi: 10.1080/14397595.2017.1285856 pubmed: 28933238
The Japanese Orthopaedic Association. Added “LOCOMO stage 3” to the clinical judgment value to determine the degree of LOCOMO. https://locomo-joa.jp/news/info/kzo81mfae075lvuc . Accessed 27 Oct 2023.
Nakamura, M. et al. Locomotive syndrome is associated with body composition and cardiometabolic disorders in elderly Japanese women. BMC Geriatr. 16, 166. https://doi.org/10.1186/s12877-016-0339-6 (2016).
doi: 10.1186/s12877-016-0339-6 pubmed: 27677265 pmcid: 5039907
Ohtsuki, M. et al. Relationships between body mass index, lifestyle habits, and locomotive syndrome in young- and middle-aged adults: A cross-sectional survey of workers in Japan. J. Occup. Health 61, 311–319 (2019).
doi: 10.1002/1348-9585.12053 pubmed: 30982230 pmcid: 6620742
Yamada, K., Yamaguchi, S., Ito, Y. M. & Ohe, T. Factors associated with mobility decrease leading to disability: A cross-sectional nationwide study in Japan, with results from 8681 adults aged 20–89 years. BMC Geriatr. 21, 651 (2021).
doi: 10.1186/s12877-021-02600-4 pubmed: 34798834 pmcid: 8603520
Jung, H., Tanaka, S. & Tanaka, R. A cutoff value for body composition on the severity of locomotive syndrome in Japanese older women: A cross-sectional study. Health Care Women Int. 29, 1–13 (2022).
doi: 10.1080/07399332.2022.2083620
Muramoto, A. et al. Waist circumference is associated with locomotive syndrome in elderly females. J. Orthop. Sci. 19, 612–619 (2014).
doi: 10.1007/s00776-014-0559-6 pubmed: 24668310
Tanaka, S. et al. Waist circumference measured by bioelectrical impedance analysis is interchangeable with manual measurement: Increased waist circumference is associated with locomotive syndrome risk. Biomed. Res. Int. 2019, 5971030. https://doi.org/10.1155/2019/5971030 (2019).
doi: 10.1155/2019/5971030 pubmed: 31662985 pmcid: 6778908
Muramoto, A. et al. Threshold values of physical performance tests for locomotive syndrome. J. Orthop. Sci. 18, 618–626 (2013).
doi: 10.1007/s00776-013-0382-5 pubmed: 23543267
Kobayashi, T., Morimoto, T., Ono, R., Otani, K. & Mawatari, M. Is grip strength useful in screening to predict the severity of locomotive syndrome?. J. Orthop. Sci. 28, 880–885 (2023).
doi: 10.1016/j.jos.2022.03.011 pubmed: 35477671
Saito, Y. et al. Evaluation of gait characteristics in subjects with locomotive syndrome using wearable gait sensors. BMC Musculoskelet. Disord. 23, 457. https://doi.org/10.1186/s12891-022-05411-9 (2022).
doi: 10.1186/s12891-022-05411-9 pubmed: 35568855 pmcid: 9107686
Nakamura, M. et al. Physical performance measures associated with locomotive syndrome in middle-aged and older Japanese women. J. Geriatr. Phys. Ther. 38, 202–207 (2015).
doi: 10.1519/JPT.0000000000000033 pubmed: 25695472
Kobayashi, T. et al. A simplified screening tool for the one-leg standing test to determine the severity of locomotive syndrome. Life (Basel) 13, 1190. https://doi.org/10.3390/life13051190 (2023).
doi: 10.3390/life13051190 pubmed: 37240835
Yoshinaga, S. et al. Lifestyle-related signs of locomotive syndrome in the general Japanese population: A cross-sectional study. J. Orthop. Sci. 24, 1105–1109 (2019).
doi: 10.1016/j.jos.2019.08.005 pubmed: 31477343
Akahane, M., Yoshihara, S., Maeyashiki, A., Tanaka, Y. & Imamura, T. Lifestyle factors are significantly associated with the locomotive syndrome: A cross-sectional study. BMC Geriatr. 17, 241. https://doi.org/10.1186/s12877-017-0630-1 (2017).
doi: 10.1186/s12877-017-0630-1 pubmed: 29047351 pmcid: 5648444
Ohsawa, T. et al. Relationship between knee osteoarthritis and the locomotive syndrome risk tests: A cross-sectional study. J. Orthop. Sci. 21, 512–516 (2016).
doi: 10.1016/j.jos.2016.03.011 pubmed: 27262920
Fujita, N. Lumbar spinal canal stenosis from the perspective of locomotive syndrome and metabolic syndrome: A narrative review. Spine Surg. Relat. Res. 5, 61–67 (2021).
doi: 10.22603/ssrr.2020-0112 pubmed: 33842711
Chiba, D. et al. Lumbar spondylosis, lumbar spinal stenosis, knee pain, back muscle strength are associated with the locomotive syndrome: Rural population study in Japan. J. Orthop. Sci. 21, 366–372 (2016).
doi: 10.1016/j.jos.2016.02.006 pubmed: 27021251
Akahane, M., Maeyashiki, A., Tanaka, Y. & Imamura, T. The impact of musculoskeletal diseases on the presence of locomotive syndrome. Mod. Rheumatol. 29, 151–156 (2019).
doi: 10.1080/14397595.2018.1452173 pubmed: 29529893
Yoshimura, N. et al. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: The research on osteoarthritis/osteoporosis against disability study. J. Bone Miner. Metab. 27, 620–628 (2009).
doi: 10.1007/s00774-009-0080-8 pubmed: 19568689
Yoshimura, N. et al. Epidemiology of locomotive syndrome using updated clinical decision limits: 6-year follow-ups of the ROAD study. J. Bone Miner. Metab. 40, 623–635 (2022).
doi: 10.1007/s00774-022-01324-8 pubmed: 35536512
Kobayashi, K. et al. Locomotive syndrome stage 1 predicts significant worsening of future motor performance: The prospective Yakumo study. Biomed. Res. Int. 2019, 1970645. https://doi.org/10.1155/2019/1970645 (2019).
doi: 10.1155/2019/1970645 pubmed: 31687379 pmcid: 6794969
Chua, K. Y. et al. Visceral fat area is the measure of obesity best associated with mobility disability in community dwelling oldest-old Chinese adults. BMC Geriatr. 21, 282. https://doi.org/10.1186/s12877-021-02226-6 (2021).
doi: 10.1186/s12877-021-02226-6 pubmed: 33910516 pmcid: 8082923
Kobayashi, T. et al. Development of a tool for screening the severity of locomotive syndrome by the loco-check. J. Orthop. Sci. 27, 701–706 (2022).
doi: 10.1016/j.jos.2021.03.011 pubmed: 33975750
Yamada, M., Moriguch, Y., Mitani, T., Aoyama, T. & Arai, H. Age-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age. Geriatr. Gerontol. Int. 14(Suppl 1), 8–14 (2014).
doi: 10.1111/ggi.12209 pubmed: 24450556
Nakaji, S. et al. Social innovation for life expectancy extension utilizing a platform-centered system used in the Iwaki health promotion project: A protocol paper. SAGE Open Med. 9, 1–13 (2021).
doi: 10.1177/20503121211002606
Ogata, T. et al. Development of a screening program to assess motor function in the adult population: A cross-sectional observational study. J. Orthop. Sci. 20, 888–895 (2015).
doi: 10.1007/s00776-015-0737-1 pubmed: 26008771 pmcid: 4575377
Seichi, A. et al. Development of a screening tool for risk of locomotive syndrome in the elderly: the 25-question Geriatric Locomotive Function Scale. J. Orthop. Sci. 17, 163–172 (2012).
doi: 10.1007/s00776-011-0193-5 pubmed: 22222445
Ryo, M. et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 28, 451–453 (2005).
doi: 10.2337/diacare.28.2.451 pubmed: 15677816
Ogawa, W. et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr. J. 71, 223–231 (2024).
doi: 10.1507/endocrj.EJ23-0593 pubmed: 38123337
Tchernof, A. & Despres, J. P. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 93, 359–404 (2013).
doi: 10.1152/physrev.00033.2011 pubmed: 23303913
Kotani, K. et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Relat. Metab. Disord. 18, 207–212 (1994).
pubmed: 8044194
Wei, J., Xu, H., Davies, J. L. & Hemmings, G. P. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 51, 1953–1956 (1992).
doi: 10.1016/0024-3205(92)90112-3 pubmed: 1453878
Lira, F. S. et al. Visceral fat decreased by long-term interdisciplinary lifestyle therapy correlated positively with interleukin-6 and tumor necrosis factor-alpha and negatively with adiponectin levels in obese adolescents. Metabolism 60, 359–365 (2011).
doi: 10.1016/j.metabol.2010.02.017 pubmed: 20359719

Auteurs

Tadashi Miyazaki (T)

Department of Medical Data Intelligence, Research Center for Health-Medical Data Science, Graduate School of Medicine, Hirosaki University, Aomori, Japan.
Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.
Department of Active Life Promotion Sciences, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Naoki Ozato (N)

Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.
Department of Active Life Promotion Sciences, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Tohru Yamaguchi (T)

Department of Medical Data Intelligence, Research Center for Health-Medical Data Science, Graduate School of Medicine, Hirosaki University, Aomori, Japan.
Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.

Yoko Sugiura (Y)

Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.
Department of Active Life Promotion Sciences, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Hiromitsu Kawada (H)

Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.

Yoshihisa Katsuragi (Y)

Research and Development, Kao Corporation, Tokyo, Japan.
Department of Active Life Promotion Sciences, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Noriko Osaki (N)

Human Health Care Products Research Laboratories, Kao Corporation, Tokyo, Japan.

Tatsuya Mikami (T)

Department of Preemptive Medicine, Research Innovation Center for Health Promotion, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Ken Ito (K)

Department of Stress Response Science, Biomedical Research Center, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Koichi Murashita (K)

Research Institute of Health Innovation, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Shigeyuki Nakaji (S)

Department of Social Medicine, Graduate School of Medicine, Hirosaki University, Aomori, Japan.

Yoshinori Tamada (Y)

Department of Medical Data Intelligence, Research Center for Health-Medical Data Science, Graduate School of Medicine, Hirosaki University, Aomori, Japan. y.tamada@hirosaki-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH